Journal of Advanced Pharmaceutical Technology & Research

ORIGINAL ARTICLE
Year
: 2020  |  Volume : 11  |  Issue : 1  |  Page : 13--19

Design and optimization of topical terbinafine hydrochloride nanosponges: Application of full factorial design, in vitro and in vivo evaluation


Reham I Amer1, Ghada H El-Osaily2, Sameh S Gad3,  
1 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo; Department of Pharmaceutics, October University for Modern Sciences and Arts, Giza, Egypt
2 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University; Department of Pharmaceutics, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt
3 Department of Pharmacology, October University for Modern Sciences and Arts, Giza, Egypt

Correspondence Address:
Dr. Ghada H El-Osaily
Faculty of Pharmacy, Modern University for Technology and Information, Elhadaba, Elwosta, Mokatam, 5th District, Cairo 12055
Egypt

Abstract

Terbinafine hydrochloride (THCl) has a broad-spectrum antifungal activity. THCl has oral bioavailability 40%, which increases dosing frequency of the drug, thus leads to some systemic side effects. Sustained release THCl nanosponges hydrogel was fabricated to deliver the drug topically. Pure THCl (drug), polyvinyl alcohol (emulsifier), and ethyl cellulose (EC, polymer to produce nanosponges) were used. THCl nanosponges were produced successfully by the emulsion solvent evaporation method. Based on a 32 full factorial design, different THCl: EC ratios and stirring rates were used as independent variables. The optimized formula selected based on the particle size and entrapment efficiency % (EE) was formulated as topical hydrogel. All formulations were found in the nanosize range except F7and F9. EE was ranged from 33.05% to 90.10%. THCl nanosponges hydrogel released more than 90% of drug after 8 h and showed the highest in vivo skin deposition and antifungal activity. The increase in drug: EC ratio was observed to increase EE and the particle size while higher stirring rate resulted in finer emulsion globules and significant reduction in EE. The drug release profile was slow from dosage form when it was incorporated in entrapped form as nanosponges rather than unentrapped one. The nanosponges hydrogel succeeded to sustain THCl release over 8 h. It showed the highest antifungal activity and skin deposition. THCl nanosponges hydrogel represents an enhanced therapeutic approach for the topical treatment of fungal infection.



How to cite this article:
Amer RI, El-Osaily GH, Gad SS. Design and optimization of topical terbinafine hydrochloride nanosponges: Application of full factorial design, in vitro and in vivo evaluation.J Adv Pharm Technol Res 2020;11:13-19


How to cite this URL:
Amer RI, El-Osaily GH, Gad SS. Design and optimization of topical terbinafine hydrochloride nanosponges: Application of full factorial design, in vitro and in vivo evaluation. J Adv Pharm Technol Res [serial online] 2020 [cited 2023 Feb 5 ];11:13-19
Available from: https://www.japtr.org/text.asp?2020/11/1/13/277926


Full Text



 Introduction



The requirements of nanotechnology are very essential as traditional formulations encounter a lot of issues such as huge side effects, nonaccurate targeting, and problems in solubility and stability. Nanosponges are porous solid particles. It can accommodate various pH, mild heating, and ecocomposite solvent.[1]

THCl is an allylamine with a broad-spectrum antifungal activity. It causes fungal cell death by inhibiting the ergosterol synthesis. Oral THCl causes severe side effects such as hepatotoxicity, anorexia, vomiting, and fatigue.[2] The present research effort was to avoid terbinafine THCl systemic side effects.

 Materials and Methods



Materials

Pure terbinafine hydrochloride (THCl) was purchased from Global Napi Pharmaceuticals, Egypt. Dichloromethane (DCM), polyvinyl alcohol (PVA), ethyl cellulose (EC), and dimethyl sulfoxide (DMSO) were purchased from Sigma Aldrich, USA. Carbopol® 934 was received as a gift from Memphis Co., Egypt. Triethanolamine was purchased from ADWIC, Egypt.

Animals

The Ethics Committee of Pharmacy Faculty, MSA University, approved the study protocol (ethical code: PT 2/EC2/2018 PD). Forty-five female Wistar rats weighing 150–200 g were used. They were acclimatized at October University for Modern Sciences and Arts Animals' House. under normal conditions and were fed with standard diet ad libitum.

Experimental design

A 32 full factorial design was used for the estimation of the drug: EC ratio (X1) and the stirring rate (X2) effects, as independent variables on two dependent variables, the particle size of the nanosponges (Y1) as well as entrapment efficiency (EE) (Y2) of all prepared possible combinations. Drug: EC ratios (w/w) and stirring rate (rpm) were optimized using a design of experiment® 7.0 at three different levels: low (−1), medium (0), and high (+1) [Table 1].{Table 1}

Preparation method

Terbinafine hydrochloride nanosponges preparation

THCl nanosponges were prepared by the emulsion solvent diffusion method. THCl and EC were dissolved in DCM (Phase 1), whereas Phase 2 was prepared by adding PVA to distilled water. Phase 1 and Phase 2 were put separately on a magnetic stirrer for 15 min. We slowly added Phase 1 to Phase 2 while stirring and then left them for 15 min on the stirrer at room temperature. The mixture was homogenized at different speeds for 2 h. After that, it filtered. The formed nanosponges were dried at 40°C for 12 h. The different ratios of drug: EC and stirring rate for the nine formulations are presented in [Table 2].[3]{Table 2}

Preparation of terbinafine hydrochloride nanosponges hydrogel

A quantity of 1.5 g of carbopol® 934 was dissolved in 100 ml distilled water. pH was neutralized using triethanolamine. Optimized THCl nanosponges equivalent weight was incorporated into the hydrogel to attain 1% w/w THCl. A conventional THCl gel was also prepared. The prepared gel was packed in a suitable vessel and kept in the refrigerator overnight to ensure complete dissolution of carbopol® 934 for further use.[4]

Characterization of terbinafine hydrochloride nanosponges

Production yield percent

Production yield (PY) % was calculated by:[5]

PY (%) = (Practical mass of nanosponges/ Theoretical mass [polymer + drug]) × 100 (1)

Particle size measurement

The particle size was determined using the particle size analyzer (Zeta sizer Nano series, UK). The formulations were diluted with an appropriate volume of phosphate buffer solution (PBS, pH 6.8). The measurements were carried out three times where the mean value was used.[6]

Entrapment efficiency

Weighed amount (20 g) of nanosponges was dissolved in 100 ml PBS (pH 6.8) and 20 ml ethanol and then sonicated for breakage. After suitable dilution, it was analyzed using ultraviolet spectrophotometer (Shimadzu-1700, Japan) at λmax = 222 nm.[5]. Finally, EE was calculated using the formula:

EE = (Actual drug content in nanosponges/Theoretical drug content) × 100 (2)

Surface morphology

The study was carried out using a scanning electron microscope (SEM, JEM-100S, JEOL, Japan). We spread over a slab a concentrated aqueous suspension and then dried it under vacuum.[7]

Characterization of terbinafine hydrochloride nanosponges hydrogel

Differential scanning calorimetry analysis

Pure THCl, THCl nanosponges, and THCl nanosponges hydrogel are tested with differential scanning calorimetry (DSC) (Mettler FP85, Switzerland) within the range 10°C/min–300°C/min using nitrogen as atmosphere and aluminum as a medium.[8]

Transmission electron microscopy

Morphology and structure of the nanosponges hydrogel were studied using the transmission electron microscopy (TEM) (JEOL, JEM 1010, Japan). The samples were stained with 2% uranyl acid.[3]

Drug content

The THCl nanosponges hydrogel was accurately weighed (2 g) and then transferred into a volumetric flask containing 10 ml PBS (pH 6.8) and then stirred for 30 min. After suitable dilution, the absorbance is measured spectrophotometrically at λmax = 222 nm.[9]

pH determination

pH was determined by weighing 50 g hydrogel and then transferred into a beaker and measured using digital pH meter (Jenway, United Kingdom).[9]

In vitro release

In vitro release studies of THCl nanosponges, THCl nanosponges hydrogel, and marketed cream were done using a modified Franz diffusion cell. The cellulose membrane was soaked overnight in PBS (pH 6.8). In Franz diffusion cell receptor compartment, 7 ml of PBS (pH 6.8) were filled. While in the donor compartment, equivalent amount of tested formula was placed on the cellulose membrane. The samples were analyzed spectrophotometrically at λmax = 222 nm, and the concentration of the drug was estimated. Each data point represented the mean of three determinations.[10]

Kinetics study

We fitted the in vitro release data to Higuchi, first-order, zero-order kinetics equations and to general exponential function: Mt/M∞= ktn, where Mt/M∞ represents solvent fractional uptake (or solute release) normalized regarding to conditions of equilibrium; n is an exponent of diffusion which is the characteristics of the release mechanism and k denotes of the polymer and the drug properties.[11]

In vitro antifungal activity study

We used the cup-plate method. Sabouraud dextrose agar was used as culture media. Inoculating was carried out by using Candida albicans (ATCC 10231) and Aspergillus niger (ATCC 16404). The mean inhibition zone was determined.[12]

In vivo skin deposition study

The animals were classified into three groups randomly with 15 animals for each: Group (1) served as control receiving THCl hydrogel, Group (2) received marketed cream, and finally Group (3) received THCl nanosponges hydrogel. Caps of bottle served as drug pools (0.05 m2) area were stuck to rats' dorsal skin. They were shaved.[13] Three animals were sacrificed from each group at each time intervals point (1, 2, 4, 6, and 8 h). Then, the dorsal rats' skin were excised and washed immediately with normal saline. The excised skin was cut into pieces and then sonicated for 30 min in 5 ml DMSO. The extract was filtered through a 0.45 μm filter membrane, and the concentrations were measured using a validated high-performance liquid chromatography analysis method. The skin analysis of variance was performed using InStat software (GraphPad InStat version 3.05 for Windows 95, GraphPad Software, San Diego, California USA, www.graphpad.com).

 Results and Discussion



Production yield percent

PY percent is represented in [Table 3]. It was observed that the increase in polymer ratios was accompanied by the increase in PY percent.[7]{Table 3}

Statistical analysis

Particle size measurement

All formulations were in nanosize range except F7 and F9, as shown in [Table 3] and [Figure 1].{Figure 1}

Coded factors equation:

Y1= +836.56 + 106.17 A + 5.67 B − 38.00 A B + 317.17 A2 − 873.33 B2 (3)

(where F = 3.30, P < 0.05, R2 = 0.9501, Adeq Precision = 4.830)

The design was evaluated by a quadratic model and equation (3) was determined based on the selected model. Y1 is the response variable (particle size) whereas A and B are the independent variables X1 and X2 coded levels, respectively, that symbolize the mean results of one factor changing at a time from low to higher levels.

From previous equation, the particle size is decreased due to the statistically significant negative coefficient value of B2 (P < 0.05) that was accompanied by increasing the stirring rate (X2), which could be attributed to the effect of homogenization speed, as the magnitude of shear stress is inversely proportional to the particle size of the prepared nanosponges [Figure 2] and [Figure 3].{Figure 2}{Figure 3}

Entrapment efficiency

EE of THCl nanosponges formulations is illustrated in [Table 3] and [Figure 4].{Figure 4}

Coded factors equation:

Y2= +66.30 + 4.69 A − 16.38 B (4)

(where F = 4.10, P < 0.05, R2 = 0.9907, Adeq Precision = 5.011).

The design was evaluated by the linear model, and equation (4) was determined based on the selected model, where Y2 is the response variable (EE). From the previous equation, EE was observed to be decreased due to the statistically significant negative coefficient value of B (P < 0.05) that was accompanied by increasing the stirring rate [Figure 5] and [Figure 6].{Figure 5}{Figure 6}

Checkpoint analysis and optimization of design

For optimizing the responses with various targets, the software design expert 7.0 suggested one formulation (F10), based on a multi-criterion decision way. The selected optimum variables values obtained were (X1 = 1:2) and (X2 = 1500 rpm). [Table 4] shows that there is a great coincidence between the predicted and observed values.{Table 4}

Surface morphology

Micrographs of optimized formula confirmed nanosponges porous nature. [Figure 7] shows that nanosponges depicted spherical, smooth surface, and uniformly porous particles. The occurrence of surface fine orifices could be due to DCM diffusion during nanosponges preparation.[7]{Figure 7}

Characterization of terbinafine hydrochloride nanosponges hydrogel

Differential scanning calorimetry analysis

DSC thermograms of pure THCl, THCl nanosponges, and THCl nanosponges hydrogel are shown in [Figure 8]a [Figure 8]b [Figure 8]c, respectively. The endothermic peak of THCl was greatly decreased in THCl nanosponges and THCl nanosponges hydrogel. That may be due to nanosponge encapsulation of THCl. In addition, it is in amorphous state after entrapment with the polymer because drug crystals completely dissolved inside the polymer matrix during the scanning of temperatures up to the melting value.[8]{Figure 8}

Transmission electron microscopy

[Figure 9] shows that TEM of the THCl nanosponges hydrogel confirmed the nanosponges incorporation into the hydrogel did not influence the nanosponges integrity.[9]{Figure 9}

Drug content and pH determination

The results of drug content are within the accepted limit (97.25 ± 3.1). The hydrogel pH values were 5.5, and hence it is acceptable and there is no risk of skin irritation.[9]

In vitro release study

The results of in vitro release studies are shown in [Figure 10]. THCl nanosponges hydrogel succeeded to sustain the release of the drug for 8 h. Hence, it was clear that drug released slowly from dosage form when it was incorporated as an entrapped form rather than the unentrapped form.{Figure 10}

Kinetics study

The results in [Table 5] show the in vitro drug release kinetic data and Korsmeyer–Peppas equation data.{Table 5}

In vitro antifungal activity study

As shown in [Table 6], the mean growth inhibition zone of THCl nanosponges hydrogel is higher than that of marketed cream and THCl hydrogel (positive control).{Table 6}

In vivo skin deposition study

[Figure 11] shows that the skin deposition of THCl nanosponges hydrogel is significantly higher than THCl hydrogel and marketed cream at P< 0.01 during almost all the study period.{Figure 11}

 Conclusion



The nanosponges hydrogel formula succeeded to sustain the release of THCl across cellulose membrane over 8 h. It showed higher antifungal activity and skin deposition than marketed cream. Hence, it represents an enhanced therapeutic approach for the treatment of fungal infection.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Selvamuthukumar S, Anandam S, Krishnamoorthy K, Rajappan M. Nanosponges: A novel class of drug delivery system – Review. J Pharm Pharm Sci 2012;15:103-11.
2Baline K, Hali F. Fonsecaea pedrosoi-induced chromoblastomycosis: About a case. Pan Afr Med J 2018;30:187.
3Aldawsari HM, Badr-Eldin SM, Labib GS, El-Kamel AH. Design and formulation of a topical hydrogel integrating lemongrass-loaded nanosponges with an enhanced antifungal effect: In vitro/in vivo evaluation. Int J Nanomedicine 2015;10:893-902.
4Jain PS, Chaudhari AJ, Patel SA, Patel ZN, Patel DT. Development and validation of the UV-spectrophotometric method for determination of terbinafine hydrochloride in bulk and in formulation. Pharm Methods 2011;2:198-202.
5Zaman M, Qureshi S, Sultana K, Hanif M, Mahmood A, Shaheryar ZA, et al. Application of quasi-emulsification and modified double emulsification techniques for formulation of tacrolimus microsponges. Int J Nanomedicine 2018;13:4537-48.
6Ng WK, Saiful Yazan L, Yap LH, Wan Nor Hafiza WA, How CW, Abdullah R. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa). Biomed Res Int 2015;2015:1-10.
7Osmani RA, Aloorkar NH, Ingale DJ, Kulkarni PK, Hani U, Bhosale RR, et al. Microsponges based novel drug delivery system for augmented arthritis therapy. Saudi Pharm J 2015;23:562-72.
8Moin A, Deb TK, Osmani RA, Bhosale RR, Hani U. Fabrication, characterization, and evaluation of microsponge delivery system for facilitated fungal therapy. J Basic Clin Pharm 2016;7:39-48.
9El-Housiny S, Shams Eldeen MA, El-Attar YA, Salem HA, Attia D, Bendas ER, et al. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: Formulation and clinical study. Drug Deliv 2018;25:78-90.
10Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol:In vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech 2011;12:279-86.
11Jagdale SC, Sali MS, Barhate AL, Kuchekar BS, Chabukswar AR. Formulation, development, and evaluation of floating pulsatile drug delivery system of atenolol. PDA J Pharm Sci Technol 2013;67:214-28.
12Wong SS, Kao RY, Yuen KY, Wang Y, Yang D, Samaranayake LP, et al. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections. PLoS One 2014;9:e85836.
13Shen LN, Zhang YT, Wang Q, Xu L, Feng NP. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm 2014;460:280-8.